Fujisawa's Antifungal Mycamine Clears FDA

The product will be rolled out by the summer, with detailing by Fujisawa's existing immunology and hospital sales forces. Micafungin is approved for prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation and treatment of esophageal candidiasis.